Literature DB >> 36233256

The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

Marià Alemany1,2.   

Abstract

Androgens are an important and diverse group of steroid hormone molecular species. They play varied functional roles, such as the control of metabolic energy fate and partition, the maintenance of skeletal and body protein and integrity and the development of brain capabilities and behavioral setup (including those factors defining maleness). In addition, androgens are the precursors of estrogens, with which they share an extensive control of the reproductive mechanisms (in both sexes). In this review, the types of androgens, their functions and signaling are tabulated and described, including some less-known functions. The close interrelationship between corticosteroids and androgens is also analyzed, centered in the adrenal cortex, together with the main feedback control systems of the hypothalamic-hypophysis-gonads axis, and its modulation by the metabolic environment, sex, age and health. Testosterone (T) is singled out because of its high synthesis rate and turnover, but also because age-related hypogonadism is a key signal for the biologically planned early obsolescence of men, and the delayed onset of a faster rate of functional losses in women after menopause. The close collaboration of T with estradiol (E2) active in the maintenance of body metabolic systems is also presented Their parallel insufficiency has been directly related to the ravages of senescence and the metabolic syndrome constellation of disorders. The clinical use of T to correct hypoandrogenism helps maintain the functionality of core metabolism, limiting excess fat deposition, sarcopenia and cognoscitive frailty (part of these effects are due to the E2 generated from T). The effectiveness of using lipophilic T esters for T replacement treatments is analyzed in depth, and the main problems derived from their application are discussed.

Entities:  

Keywords:  anabolic steroids; androgens; dehydroepiandrosterone; dihydrotestosterone; estradiol; metabolic regulation; metabolic syndrome; senescence; testosterone; testosterone replacement therapy

Mesh:

Substances:

Year:  2022        PMID: 36233256      PMCID: PMC9569951          DOI: 10.3390/ijms231911952

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   6.208


  703 in total

1.  A Portal Circulation from the Pituitary to the Hypothalamic Region.

Authors:  G Popa
Journal:  J Anat       Date:  1930-10       Impact factor: 2.610

2.  Neuro-steroids: 3 beta-hydroxy-delta 5-derivatives in rat and monkey brain.

Authors:  P Robel; E Bourreau; C Corpéchot; D C Dang; F Halberg; C Clarke; M Haug; M L Schlegel; M Synguelakis; C Vourch
Journal:  J Steroid Biochem       Date:  1987       Impact factor: 4.292

3.  Metabolism and plasma half life of ( 14 C)testosterone plus ( 3 H)testosterone ( 35 S)sulfate perfused through human liver or injected intravenously.

Authors:  P Knapstein; W Wortmann; C Krämer
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-09

4.  17β-estradiol improves hepatic mitochondrial biogenesis and function through PGC1B.

Authors:  Bel M Galmés-Pascual; Antonia Nadal-Casellas; Marco Bauza-Thorbrügge; Miquel Sbert-Roig; Francisco J García-Palmer; Ana M Proenza; Magdalena Gianotti; Isabel Lladó
Journal:  J Endocrinol       Date:  2016-11-24       Impact factor: 4.286

5.  The mechanism of the synthesis of 16-androstenes in human testicular homogenates.

Authors:  J J Weusten; G Legemaat; M P van der Wouw; A G Smals; P W Kloppenborg; T Benraad
Journal:  J Steroid Biochem       Date:  1989-05       Impact factor: 4.292

6.  Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).

Authors:  Mario Maggi; Frederick C W Wu; Thomas H Jones; Graham Jackson; Hermann M Behre; Geoffrey Hackett; Antonio Martin-Morales; Giancarlo Balercia; Adrian S Dobs; Stefan T E Arver; Marcello Maggio; Glenn R Cunningham; Andrea M Isidori; Richard Quinton; Olivia A Wheaton; Flora S Siami; Raymond C Rosen
Journal:  Int J Clin Pract       Date:  2016-10       Impact factor: 2.503

7.  Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.

Authors:  Bronwyn A L Crawford; Peter Y Liu; Mary T Kean; Jane F Bleasel; David J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

8.  AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.

Authors:  C Steidle; S Schwartz; K Jacoby; T Sebree; T Smith; R Bachand
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

9.  Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans.

Authors:  Edward P Weiss; Dennis T Villareal; Luigi Fontana; Dong-Ho Han; John O Holloszy
Journal:  Aging (Albany NY)       Date:  2011-05       Impact factor: 5.682

Review 10.  The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology.

Authors:  Rachel Bleach; Marie McIlroy
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.